Financial Performance & Guidance - Allegro's 1QFY26 net sales reached $203 million, exceeding the high end of guidance[10] - The gross margin for 1QFY26 was 48.2%, surpassing the guidance and showing a 260 bps quarter-over-quarter improvement[10, 14] - EPS for 1QFY26 was $0.09, above the midpoint of guidance[10, 14] - Free cash flow for 1QFY26 was $51 million, representing 25% of sales[14] - The company made $35 million in voluntary debt repayments during the quarter[14] - 2QFY26 sales guidance is between $205 million and $215 million, implying 12% year-over-year growth[19] - 2QFY26 gross margin is expected to be between 48% and 50%, and EPS between $0.10 and $0.14[19] Business Growth & Strategy - Net sales increased 22% year-over-year[15] - Auto sales increased 13% year-over-year, driven by e-Mobility which grew 31% year-over-year[15] - Industrial and Other sales increased 50% year-over-year, with strength in Data Center and Robotics & Automation[15] - 75% of design wins were in strategic focus areas, including xEV traction inverters and ADAS/EV applications[15]

Earnings Presentation Q2 2025 July 31, 2025 Forward-looking Statements and Non-GAAP Measures 2 • These slides may contain forward-looking statements. These statements relate to future events or to future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these f ...

Financial Performance Highlights - Second quarter 2025 revenue reached $272 million, a 41% increase driven by growth in Aviation distribution and MRO businesses, as well as contributions from recent acquisitions[11] - Adjusted EBITDA for the second quarter 2025 was $43 million, representing 16% of revenue, a 52% increase due to distribution program execution, increased MRO activity, strong OEM licensed manufacturing program performance, and acquisitions[11] - Adjusted Net Income for the second quarter 2025 was $20 million, and Adjusted diluted earnings per share was $0.97, representing increases of 149% and 106% respectively[11] Business Developments - The company completed the sale of the Fleet segment, repositioning itself as a pure-play Aviation Aftermarket business[6] - Turbine Weld Industries ("Turbine Weld") was acquired, expanding MRO engine component capabilities[6] - A new 5-year authorized services center agreement was signed with Eaton to support aftermarket MRO for Eaton hydraulics across the Americas[6] Balance Sheet and Capital Structure - Adjusted Net Leverage was 2.2x, including the Fleet sale and acquisition of Turbine Weld[11, 23] - Net Debt outstanding was $362 million, while cash and revolver availability was $333 million[23] - Second quarter 2025 Free Cash Flow was $6 million, driven by disciplined working capital management and record profitability[23] FY 2025 Guidance - Revenue Guidance: Reaffirming 35% to 40% year-over-year growth[20] - Aviation Adjusted EBITDA Margin Guidance: Increasing to 16.5% to 17%, the high-end of previously provided range[20]

EARNINGS CALL PRESENTATION Q2 2025 DISCLAIMER The financial results in this document reflect preliminary, unaudited results, which are not final until the Company's Quarterly Report on Form 10-Q is filed. With the exception of historical information, certain statements contained or incorporated by reference herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, a ...

Financial Performance - Q2 2025 sales reached $1.14 billion, a 4% year-over-year increase[4] - Adjusted EBITDA for Q2 2025 was $208 million, up 14% year-over-year, with a margin of 18.2%, a 150 bps increase[4] - Adjusted EPS for Q2 2025 was $0.74, compared to $0.60 in Q2 2024[4, 5] - Adjusted Free Cash Flow was $93 million, a 94% year-over-year increase[6] Segment Performance (Aerospace & Defense) - Aerospace & Defense (A&D) accounted for 67% of total sales, with $762 million in Q2[10, 11] - Commercial Jet Engines saw a 27% year-over-year growth in Q2 and 31% year-to-date, with expected growth exceeding 20% for 2025[10, 13] - HPMC (High Performance Materials & Components) segment margin was 23.7% in Q2, up 350 bps year-over-year[10] - AA&S (Advanced Alloys & Solutions) segment margin was 14.4%, a sequential dip due to defense, airframe, and energy timing[10] Outlook and Capital Allocation - The company expects an Adjusted EBITDA between $810 million and $840 million for the full year 2025[20] - The company expects an Adjusted EPS between $2.90 and $3.07 for the full year 2025[20] - The company expects a Free Cash Flow between $270 million and $350 million for the full year 2025[20] - $250 million in share repurchases were made in Q2, with over $800 million repurchased since 2022 at an average price of ~$48 per share[10]

EARNINGS PRESENTATION Q2 2025 July 31, 2025 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties and reflect the Company's judgment as of the date of this presentation. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements. Some of these forward-looking statements may contain words like "will," "believe," "ma ...

EARNINGS PRESENTATION July 31 | 2025 FORWARD LOOKING STATEMENTS & OTHER INFORMATION This document contains forward-looking statements. within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Company's representatives may also make forward-looking statements orally or in writing from time to time. Statements in this document that are not historical facts, including, stateme ...

Financial Performance - Total Q2 Revenue reached $63.2 million[6], with MACI contributing $53.5 million[6], Epicel $8.6 million[6], and NexoBrid $1.2 million[6] - MACI revenue experienced a growth of 21% reaching $53.5 million[10] - Gross margin increased to 74%, up over 400 bps compared to Q2 2024[10] - Adjusted EBITDA increased by 112% to $13.4 million[10] - The company holds $164 million in cash and investments[10] Business Highlights - Approximately 600 surgeons have been trained on MACI Arthro to date[10] - MACI implants for small femoral condyle defects increased by more than 40% in Q2 compared to the prior year[10] - NexoBrid second quarter revenue increased 52% vs prior year[10] - The company received FDA IND clearance for the MACI Ankle clinical study and remains on track to initiate the study in 2H 2025[10] MACI Arthro Launch - MACI Arthro trained surgeons continue to demonstrate expanded MACI utilization[14] - MACI implants for trochlea defects account for nearly 20% of MACI Arthro implants to date[14]

Q2 2025 Supplemental Materials July 31, 2025 Forward-Looking Statements This presentation and the live webcast and Q&A session which will be held at 530 a.m. Pacific Time/830 a.m. Eastern Time on Thursday, July 31, 2025 contain "forward-looking statementsˮ within the meaning of the "safe harborˮ provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our vision to connect one billion users with optimism and civility, our vision to reach 10% of t ...

Q2 2025 Earnings Conference Call July 31, 2025 Forward Looking Statements Certain information in this presentation includes forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 (the "Exchange Act") and the Private Securities Litigation Reform Act of 1995) regarding future events or our future financial performance that involve certain contingencies and uncertainties, including those discussed in our Annual Report on F ...